Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
99.93
+3.13 (3.23%)
May 29, 2026, 3:00 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26,45224,53816,49414,01410,00814,112
Market Cap Growth
-3.07%48.77%17.70%40.02%-29.08%-9.11%
Enterprise Value
24,75423,57815,21312,6589,44313,028
Last Close Price
99.9392.7062.3152.9441.7058.80
Forward PE
47.7435.5135.5135.5135.51-
PS Ratio
17.0930.2830.9536.2633.1174.13
PB Ratio
15.4422.7113.178.5212.7111.26
P/TBV Ratio
15.6923.3713.708.9614.9813.07
P/OCF Ratio
32.46-431.73---
EV/Sales Ratio
15.9929.0928.5432.7631.2468.44
Debt / Equity Ratio
0.571.050.830.540.700.18
Net Debt / Equity Ratio
-0.99-0.83-0.92-0.83-0.63-0.78
Net Debt / EBITDA Ratio
-3.604.476.653.821.032.11
Net Debt / FCF Ratio
-2.684.2720.094.601.091.86
Asset Turnover
0.470.270.180.170.180.10
Inventory Turnover
0.520.460.260.300.370.19
Quick Ratio
2.151.541.712.081.573.35
Current Ratio
2.361.711.882.221.773.69
Return on Equity (ROE)
33.83%-14.16%-10.37%-24.27%-47.59%-31.38%
Return on Assets (ROA)
8.14%-5.08%-4.60%-10.91%-19.70%-17.02%
Return on Capital Employed (ROCE)
18.30%-15.80%-13.30%-22.70%-57.30%-37.10%
Earnings Yield
1.88%-0.66%-0.84%-1.99%-4.57%-3.20%
FCF Yield
2.39%-0.86%-0.35%-2.11%-4.59%-3.72%
Buyback Yield / Dilution
-0.49%0.85%-3.71%-6.74%0.19%-2.20%